E33G (p.Glu33Gly) variant of TCF7L2 (Transcription factor 7-like 2)

E33G (p.Glu33Gly) in TCF7L2 (Transcription factor 7-like 2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Inborn genetic diseases. The available variant effect predictions contribute to a CATVariant prioritization score of 0.48 / 1. The record also includes population frequency data and structural context.

E33G (p.Glu33Gly) variant details